Dong-A University Hospital

Busan, Busan Gwang'yeogsi 49201

0 studies enrolling now · 2 studies all time

What they study most

B-cell Malignancies, Pancreatic Ductal Carcinoma

Studies at this site

• Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies — Running, not enrolling
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early